Clinical Trials Logo

Acute Leukemia clinical trials

View clinical trials related to Acute Leukemia.

Filter by:

NCT ID: NCT04904211 Completed - Acute Leukemia Clinical Trials

Feasiblity and Safety of Home-based Intensive Chemotherapy

Start date: January 2017
Phase: N/A
Study type: Interventional

a multicenter single-arm feasibility and safety study of home-based intensive chemotherapy in patients with newly diagnosed acute myeloid leukemia and their quality of life and psychological wellbeing. This national study included patients from six sites in Denmark who received intensive chemotherapy on programmed CADD Solis infusion pumps through a central venous catheter and were also managed as outpatients during treatment-induced pancytopenia.

NCT ID: NCT04899882 Recruiting - Acute Leukemia Clinical Trials

Physical Fitness Impact of Early Physiotherapy Intervention With a Standardized Exercise Therapy Program in Adult Patients Receiving Intensive Induction Chemotherapy for Treatment of Acute Leukemia During Extended Hospitalization.

KinHémo
Start date: January 5, 2022
Phase: N/A
Study type: Interventional

This study aimed to investigate the impact of Physical therapy in adult patients receiving intensive induction chemotherapy for the treatment of acute leukemia during prolonged hospitalization. The study cohort included 150 patients. Primary objective is to compare the effect of a standardized rehabilitation program on physical deconditioning. This study has several secondary objectives of comparing and analyzing the status of sarcopenia, muscle strength, physical performance and the psychic dimension of this intervention. The 6 minutes walking test, Handgrip strength, impedance measurement, computed tomography, Short Physical Performance were used as measures of physical function. Hospital Anxiety and Depression Scale and European Organization for the Research and Treatment of Cancer-Quality of Life-Questionnaire-30 (EORTC-QLQ-30) were used as measures of depression and anxiety and quality of life of cancer patients. To investigate the impact of physical therapy, patients were assigned to the physical therapy group (experimental group) or the control group.These results will thus make it possible to promote access to physiotherapy and rehabilitation care, from diagnosis and during hospitalization, and to standardize practices.

NCT ID: NCT04767165 Recruiting - Acute Leukemia Clinical Trials

Quantitative MRI of Bone Marrow in Patients With Acute Lymphoblastic Leukemia

Start date: February 22, 2021
Phase: N/A
Study type: Interventional

The study is aimed at assessing changes in the bone marrow of patients from 6 to 18 years old with a diagnosis of acute lymphoblastic leukemia during chemotherapy. Patients of the same age without hematological diseases will be recruited as a control group.

NCT ID: NCT04767152 Recruiting - Acute Leukemia Clinical Trials

Evaluation of Brain Changes in ALL Patients on Therapy

Start date: February 16, 2021
Phase: N/A
Study type: Interventional

The study is aimed at assessing changes in the brain of patients from 6 to 18 years old with a diagnosis of acute lymphoblastic leukemia during chemotherapy.

NCT ID: NCT04674345 Recruiting - Acute Leukemia Clinical Trials

Sorafenib Maintenance for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3 Negative Acute Leukemia

Start date: December 15, 2020
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of sorafenib maintenance after allo-HSCT in FLT3-negative acute leukemia patients.

NCT ID: NCT04597086 Completed - Acute Leukemia Clinical Trials

Bright White Light Therapy for the Improvement of Sleep, Fatigue, Distress, Depression, and Anxiety in Hospitalized Leukemia Patients

Start date: September 14, 2020
Phase: N/A
Study type: Interventional

This trial investigates how well bright white light therapy works in improving sleep, fatigue, distress, depression, and anxiety, side effects that are often experienced during an intense leukemia treatment regimen, in hospitalized leukemia patients. Bright white light therapy may help to control these symptoms, and information from this study may help doctors and nurses learn more about methods for decreasing these symptoms.

NCT ID: NCT04552912 Completed - Physical Activity Clinical Trials

Physical Activity to Improve Patient Reported Outcomes for Adults With Acute Leukemia

Build Stamina
Start date: January 15, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to test the efficacy of an evidence-based tailored physical activity program adapted for adults with acute leukemia. Implementation-related process evaluation of the physical activity program will also be assessed.

NCT ID: NCT04551235 Recruiting - Acute Leukemia Clinical Trials

Establishing Automatic Method of Counting and Classify Bone Marrow and Peripheral Blood Cells

Start date: August 28, 2020
Phase:
Study type: Observational

Counting and classification of blood cells in a bone marrow smear and peripheral blood smear are essential to clinical hematology. To this date, this procedure has been carried out in a manual manner in the great majority of clinical settings. There is often inconsistency in the counting result between different operators largely due to its manual nature. There has not been an effective and standard method for blood smear preparation and automatic counting and classification. The recent advent of deep neural network for medical image processing introduced new opportunities for an effective solution of this long-standing problem. Numerous results have been published on the effectiveness of convolutional neural network in clinical image recognition task.

NCT ID: NCT04451200 Not yet recruiting - Acute Leukemia Clinical Trials

Sequential and Personalized PK-guided Busulfan Administration in the Frame of the Conditiong Regimen for Allo-HSCT in Patients With Malignant Hemopathies Ineligible for the Standard Myeloablative Conditioning

BUSEQ
Start date: November 2020
Phase: Phase 2
Study type: Interventional

Because the anti-leukemic activity of busulfan, this dug is largely used in graft conditioning but in elderly and/or cormobid patienth an excess of toxicity is observed. This study focus on the possibility of significanty reducing this toxicity by customizing the doses of busulfan to individual PK parameters.

NCT ID: NCT04409379 Completed - Acute Leukemia Clinical Trials

Association Between Telomere Length and Cardiac Dysfunction

Start date: January 1, 2019
Phase:
Study type: Observational

Compelling epidemiological evidence indicates that alterations of relative telomere length (RTL) are associated with cardiac dysfunction caused by chemotherapy in children with acute leukemia (AL).The aim of this study was to explore association between RTL content in peripheral blood cells could be used as a risk predictor for severity of cardiac damage.